Suppr超能文献

对由(原)NCIMB 30084组成的饲料添加剂进行评估,以用于所有动物物种的授权续期(科汉森公司)。

Assessment of the feed additive consisting of (formerly ) NCIMB 30084 for all animal species for the renewal of its authorisation (Chr. Hansen A/S).

作者信息

Bampidis Vasileios, Azimonti Giovanna, de Lourdes Bastos Maria, Christensen Henrik, Durjava Mojca, Dusemund Birgit, Kouba Maryline, López-Alonso Marta, Puente Secundino López, Marcon Francesca, Mayo Baltasar, Pechová Alena, Petkova Mariana, Ramos Fernando, Sanz Yolanda, Villa Roberto Edoardo, Woutersen Ruud, Saarela Maria, Amaduzzi Angelica, Anguita Montserrat, Alija-Novo Natalia, Brozzi Rosella, García-Cazorla Yolanda, Innocenti Matteo Lorenzo, Revez Joana, Firmino Joana P

出版信息

EFSA J. 2023 Jul 27;21(7):e08167. doi: 10.2903/j.efsa.2023.8167. eCollection 2023 Jul.

Abstract

Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on assessment of the application for renewal of authorisation (previously ) NCIMB 30084 as a technological feed additive, silage additive for all animal species. The applicant has provided evidence that the additive currently on the market complies with the existing conditions of authorisation. There is no new evidence that would lead the FEEDAP Panel to reconsider its previous conclusions. Thus, the Panel concludes that the additive remains safe for all animal species, consumers and the environment under the authorised conditions of use. Regarding user safety, the additive should be considered as a respiratory sensitiser. No conclusions can be drawn on the skin sensitisation, and skin and eye irritancy potential of the additive. There is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.

摘要

应欧盟委员会要求,动物饲料添加剂及产品或物质专家委员会(FEEDAP)被要求就NCIMB 30084作为所有动物种类的技术饲料添加剂、青贮饲料添加剂续期授权申请的评估提供科学意见。申请人提供的证据表明,目前市场上的添加剂符合现有授权条件。没有新的证据会导致FEEDAP专家委员会重新考虑其先前的结论。因此,专家委员会得出结论,在授权使用条件下,该添加剂对所有动物种类、消费者和环境仍然是安全的。关于用户安全,该添加剂应被视为呼吸道致敏剂。关于该添加剂的皮肤致敏性、皮肤和眼睛刺激性,无法得出结论。在续期授权的背景下,无需评估该添加剂的功效。

相似文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验